Business Segments Bayer AG

Equities

Real-time Estimate Tradegate Other stock markets 01:34:13 21/05/2026 pm IST			5-day change	1st Jan Change
38.88 ^EUR	-0.88%		+1.81%	+5.03%

12:04pm	Bayer says FDA grants priority review designation for finerenone	RE
19/05	Can Nvidia Do It Again?

Breakdown by Business Segment (EUR)

Fiscal Period: December	2021	2022	2023	2024	2025
Nitrogenous Fertilizers
Crop Science	2.02TCr	2.52TCr	2.33TCr	2.23TCr	2.17TCr
Total Assets	-	-	-	-	-
CAPEX	-124Cr	-178.6Cr	-160.1Cr	-145.1Cr	-131Cr
EBITDA	469.8Cr	686.7Cr	503.8Cr	432.5Cr	418.8Cr
D&A	225.7Cr	459.6Cr	237.2Cr	246.6Cr	257.5Cr
Operating Income	-50Cr	295Cr	-348.6Cr	-275.6Cr	-253.2Cr
Pharmaceutical Products
Pharmaceuticals	1.84TCr	1.93TCr	1.81TCr	1.82TCr	1.78TCr
Total Assets	-	-	-	-	-
CAPEX	-130.8Cr	-131.7Cr	-121.2Cr	-129.3Cr	-112Cr
EBITDA	577.9Cr	587.3Cr	518.9Cr	472.2Cr	452.5Cr
D&A	87Cr	122.7Cr	91Cr	94Cr	93Cr
Operating Income	446.9Cr	498.5Cr	397.1Cr	279Cr	312.7Cr
Non-Prescription Drugs
Consumer Health	529.3Cr	608Cr	603.4Cr	587.5Cr	580.8Cr
Total Assets	-	-	-	-	-
CAPEX	-21Cr	-20Cr	-17Cr	-21Cr	-21Cr
EBITDA	119Cr	136.7Cr	141.1Cr	136.6Cr	134.1Cr
D&A	33Cr	36Cr	36Cr	38Cr	38Cr
Operating Income	81Cr	96Cr	115.8Cr	102.8Cr	91Cr
Outsourced Business Services
All Other	20Cr	22Cr	24Cr	33Cr	30Cr
Total Assets	-	-	-	-	-
CAPEX	-9.3Cr	-4.3Cr	-10Cr	-7.1Cr	-24Cr
EBITDA	9.5Cr	15Cr	16Cr	6.2Cr	28Cr
D&A	6.9Cr	7.1Cr	6.7Cr	7.2Cr	8Cr
Operating Income	-2.7Cr	7.9Cr	9.6Cr	-1.1Cr	20Cr
Enabling Functions and Consolidation	-50L	-10L	-3.6Cr	-7.2Cr	-4.8Cr
Total Assets	-	-	-	-	-
CAPEX	-16Cr	-29Cr	-24Cr	-24Cr	-27Cr
EBITDA	-58Cr	-74Cr	-9.5Cr	-35Cr	-66Cr
D&A	21Cr	24Cr	20Cr	20Cr	20Cr
Operating Income	-140.2Cr	-195.9Cr	-112.7Cr	-112.2Cr	-278Cr
Total Assets	-	-	-	-	-
Plastic and Synthetic Resins
Covestro	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
EBITDA	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Veterinary Drugs
Animal Health	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
EBITDA	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-

Geographical breakdown of sales (EUR)

Fiscal Period: December	2021	2022	2023	2024	2025
United States	1.34TCr	1.57TCr	1.46TCr	1.48TCr	1.51TCr
Total Assets	4.8TCr	4.62TCr	3.95TCr	3.71TCr	3.47TCr
Europe / Middle East / Africa (Excl. Germany & Switzerland)	1.06TCr	1.14TCr	1.11TCr	1.1TCr	1.04TCr
Total Assets	428.5Cr	479.2Cr	445.8Cr	416Cr	618.3Cr
Brazil	347.6Cr	532.2Cr	496.7Cr	431.7Cr	437.6Cr
Total Assets	163.2Cr	183.6Cr	146.6Cr	107Cr	106.5Cr
Asia / Pacific (Excl.China)	499.3Cr	519.2Cr	474.5Cr	447.1Cr	405Cr
Total Assets	130.7Cr	120.3Cr	97Cr	86Cr	71Cr
China	385.6Cr	425.9Cr	362.4Cr	360Cr	346.8Cr
Total Assets	62Cr	68Cr	70Cr	58Cr	53Cr
Latin America (Excl. Brazil)	315.6Cr	396.6Cr	396.1Cr	376.1Cr	345.5Cr
Total Assets	122.4Cr	143.8Cr	129.5Cr	133.8Cr	125.6Cr
Germany	254.5Cr	247.7Cr	244.8Cr	241Cr	258.4Cr
Total Assets	1.55TCr	1.52TCr	1.52TCr	1.51TCr	1.14TCr
North America (Excl.United States)	155.5Cr	188.6Cr	166.7Cr	168.1Cr	162.7Cr
Total Assets	158.3Cr	148.4Cr	106.3Cr	89Cr	81Cr
Switzerland	54Cr	60Cr	57Cr	58Cr	48Cr
Total Assets	493.3Cr	466.5Cr	432.4Cr	442.8Cr	464.1Cr
Europe / Middle East / Africa	-	-	-	-	-
D&A	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Operating Income	-	-	-	-	-
Latin America	-	-	-	-	-
D&A	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Operating Income	-	-	-	-	-
Asia / Pacific	-	-	-	-	-
D&A	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Operating Income	-	-	-	-	-
Reconciliation	-	-	-	-	-
D&A	-	-	-	-	-
Total Assets	-	-	-	-	-
Operating Income	-	-	-	-	-
North America	-	-	-	-	-
D&A	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Operating Income	-	-	-	-	-